About 1 result found for searched term "Mitazalimab" (0.062 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24893 | Mitazalimab | TNF Receptor |
| ADC-1013; JNJ-64457107 | ||
| Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid microenvironment. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
